Immunology

A unique window into 'original antigenic sin'

Our immune systems react most strongly to the viral strains we encountered in our childhoods. Scientists call this original antigenic sin (OAS)—the body's first blush with a virus like influenza or COVID being the "original ...

Diseases, Conditions, Syndromes

Promising pre-clinical results for COVID-19 vaccine

A COVID-19 vaccine candidate developed by the University of Saskatchewan's (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) has cleared another major milestone in moving towards ...

Diseases, Conditions, Syndromes

Novel schistosomiasis vaccine: New phase of clinical studies

The Oswaldo Cruz Foundation (Fiocruz) at Rio de Janeiro, Brazil, will start the phase II clinical trials of a vaccine for schistosomiasis, called 'Sm14 Vaccine'. The initiative is one of the health research and development ...

Psychology & Psychiatry

Cocaine vaccine passes key testing hurdle

Researchers at Weill Cornell Medical College have successfully tested their novel anti-cocaine vaccine in primates, bringing them closer to launching human clinical trials. Their study, published online by the journal Neuropsychopharmacology, ...

Diseases, Conditions, Syndromes

Will the COVID-19 vaccine work as well in patients with obesity?

When researchers began to develop what they hoped would be an effective COVID-19 vaccine, they already knew that H1N1 influenza—a novel virus, like COVID-19 – more severely affected patients with overweight or obesity. ...

page 2 from 3